Based in Vienna, Austria, Besurence GmbH is a leader in manufacturing and distribution of CE-certified in-vitro diagnostic test systems for both, home- and professional use to detect or diagnose critical medical conditions, allergies and fertility problems. Our products include diagnostic solutions for the detection of antibodies to HIV, tests for antibodies to HCV, tests to identify an infection with Malaria P.F. & P.V., Dengue or H. pylori, Celiac disease as well as a highly sensitive pregnancy test and a fertility test for women. Rapid diagnostics offer an effective decentralized, simple and low-tech solution to screening a population on different health problems. Our portfolio of diagnostic products is sold globally to various clinical laboratories, hospitals and other public health organizations, distributors, government agencies, physicians' offices, and commercial entities. Our over the counter products are available in pharmacies across Europe, Middle East, Africa and Asia. It is our vision to provide highly accurate but easy to handle diagnostic solutions with substantial value to existing and emerging healthcare needs. Our products will enable an immediate answer to crucial health related questions - empowering patients and healthcare professionals to make critical decisions to improve and protect their life.
View Top Employees from BesurenceWebsite | http://www.besurence.com |
Revenue | $5 million |
Employees | View employees |
Address | Hietzinger Hauptstraße 46, Vienna, Vienna, AT |
Phone | +43 1 503597920 |
Industry | Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Besurence employee's phone or email?
The Besurence annual revenue was $5 million in 2024.
Besurence is based in Vienna, Vienna.
The NAICS codes for Besurence are [32, 325, 325413, 3254, 32541].
The SIC codes for Besurence are [283, 28].